共 9 条
[1]
Changes in Thymosin-α 1 Content in Patients with Nonspecific Gynecologic Diseases Depending on Inflammation Type and Efficacy of Antiinflammatory and Immunomodulating Therapy.[J].A. V. Shurlygina;G. I. Litvinenko;T. I. Dergacheva;V. A. Trufakin.Kluwer Academic Publishers-Plenum Publishers.2000, 9
[2]
Combination treatment with zidovudine; thymosin α 1 and interferon-α in human immunodeficiency virus infectionand interferon-α in human immunodeficiency virus infection.[J].Enrico Garaci;Giovanni Rocchi;Luigi Perroni;Cartesio D'Agostini;Fabrizio Soscia;Sandro Grelli;Antonio Mastino;Cartesio Favalli.International Journal of Clinical & Laboratory Research.1994, 1
[5]
Modulation of terminal deoxynucleotidyl transferase activity by thymosin.[J].Shu-Kuang Hu;Teresa L. K. Low;Allan L. Goldstein.Molecular and Cellular Biochemistry.1981, 1
[8]
[9]
Bos JL Mutational activation of the k-ras oncogene: A possible pathogenetic factor in adenocarcinoma of the lung..Rodenhis S; Van de Wetering ML; Mooi WJ; Evers SG; Van Zandwijk N;.N Engl J Med.1987,

